Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: TP0501 - Pharmaco-Scintigraphic-Study [Phase 1]
Phase 1 pharmaco-scintigraphic study of TP0501 in ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Trial of Rosiglitazone for Ulcerative Colitis [Phase 2]
Phase 2 trial assessing rosiglitazone for ulcerative colitis has been completed with results posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Vitamin D Treatment in Ulcerative Colitis [NA]
A clinical trial investigating vitamin D treatment for ulcerative colitis has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2014-11-20Clinical Trial Update: Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease [Phase 2]
A Phase 2 trial of low-dose naltrexone for inflammatory bowel disease has been withdrawn. The conditions involved include Crohn's disease an…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients [Phase 2]
A Phase 2 pharmacokinetics/pharmacodynamics biomarker study in active ulcerative colitis was completed, with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing [Phase 4]
Phase 4 trial update evaluating intestinal inflammation in ankylosing spondylitis and how adalimumab affects mucosal healing.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Rituximab in Active Ulcerative Colitis [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating rituximab for active ulcerative colitis is summarized in this update.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults [Phase 1]
Phase 1 study assessing the absolute bioavailability, safety, and tolerability of subcutaneous GS-5745 in healthy adults. Ulcerative Colitis…
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents [NA]
A Basel-based clinical trial is evaluating whether aerobic exercise training affects inflammatory bowel disease outcomes in children and ado…
-
FDA approval · 2014-10-16FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIALDA (mesalamine) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-09-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved Humira's supplemental application submitted by Cordavis Limited. The approval acts as a supplemental approval to the existing H…
-
FDA approval · 2014-09-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) to add Cordavis Limited as a supplier. This action supports continued av…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Disease Course in an IBD Cohort in the Era of Biological Treatment
This clinical trial update summarizes the disease course of an inflammatory bowel disease cohort (Crohn's disease and ulcerative colitis) in…
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: CLE for Differential Diagnosis of IBD
A completed clinical trial evaluating confocal laser endomicroscopy for differentiating Crohn's disease and ulcerative colitis in inflammato…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses [NA]
This terminated clinical trial evaluated a bioabsorbable staple line reinforcement device for colorectal, coloanal, and ileoanal anastomoses…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients [Phase 3]
A Phase 3 open-label trial of tacrolimus (FK506) in patients with refractory ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients [Phase 3]
A Phase 3 trial of tacrolimus (FK506) in moderate-to-severe refractory ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [NA]
A terminated pediatric trial assessed safety and compliance of once-daily mesalamine in children with Ulcerative Colitis; results are posted…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis [Phase 2]
Biogen completed a Phase 2 study of interferon beta-1a (Avonex) in active ulcerative colitis, with trial results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 2]
A placebo-controlled Phase 2 trial evaluated recombinant factor XIII (rFXIII) in adults with mild to moderate active ulcerative colitis; the…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis [Phase 3]
Phase 3 randomized, placebo-controlled trial of budesonide MMX 6 mg and 9 mg in ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis [Phase 3]
Phase 3 randomized, placebo-controlled trial of budesonide MMX 6 mg and 9 mg in ulcerative colitis completed; results posted in 2014.
-
FDA approval · 2014-07-30FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for CANASA (mesalamine) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial update for Vedolizumab in moderate to severe ulcerative colitis; the study completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease [Phase 2]
Phase 2 long-term safety results of vedolizumab (MLN0002) in patients with ulcerative colitis and Crohn's disease have been reported.